Van Assche, G., Sandborn, W. J., Feagan, B. G., Salzberg, B. A., Silvers, D., Monroe, P. S., Pandak, W. M., Anderson, F. H., Valentine, J. F., Wild, G. E., Geenen, D. J., Sprague, R., Targan, S. R., Rutgeerts, P., Vexler, V., Young, D., & Shames, R. S. (2006). daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. Gut, 55(11), 1568–1574. http://access.bl.uk/ark:/81055/vdc_100137793558.0x00004a